Detalhe da pesquisa
1.
Platelet Transfusion before CVC Placement in Patients with Thrombocytopenia.
N Engl J Med
; 388(21): 1956-1965, 2023 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37224197
2.
First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group.
Lancet Oncol
; 24(7): 757-771, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37329889
3.
Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours.
BMC Cancer
; 23(1): 205, 2023 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36870947
4.
Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era.
Br J Cancer
; 124(2): 399-406, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33046804
5.
MYD88 mutations identify a molecular subgroup of diffuse large B-cell lymphoma with an unfavorable prognosis.
Haematologica
; 105(2): 424-434, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31123031
6.
Predictors of the corrected count increment after platelet transfusion, a secondary analysis of the PACER randomized controlled trial.
Am J Hematol
; 98(11): E305-E308, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37605361
7.
Prognostic parameters for response to enzalutamide after docetaxel and abiraterone treatment in metastatic castration-resistant prostate cancer patients; a possible time relation.
Prostate
; 76(1): 32-40, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26390914
8.
Enzalutamide as a Fourth- or Fifth-Line Treatment Option for Metastatic Castration-Resistant Prostate Cancer.
Oncology
; 91(5): 267-273, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27544669
9.
Clinical activity and tolerability of enzalutamide (MDV3100) in patients with metastatic, castration-resistant prostate cancer who progress after docetaxel and abiraterone treatment.
Cancer
; 120(7): 968-75, 2014 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24382803
10.
Trastuzumab plus pertuzumab for HER2-amplified advanced colorectal cancer: Results from the drug rediscovery protocol (DRUP).
Eur J Cancer
; 202: 113988, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38471288
11.
Patients with Rare Cancers in the Drug Rediscovery Protocol (DRUP) Benefit from Genomics-Guided Treatment.
Clin Cancer Res
; 28(7): 1402-1411, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35046062
12.
Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial.
J Clin Oncol
; 40(11): 1220-1230, 2022 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35084987
13.
Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer: A multicenter prospective cohort.
Eur J Surg Oncol
; 47(3 Pt B): 699-707, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33280952
14.
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial.
J Clin Oncol
; 38(16): 1763-1773, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32105518